Quanterix Corporation (QTRX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $47.00K; Additional Paid in Capital, Common StockUSD $882.04M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.17M; Retained Earnings (Accumulated Deficit)USD $-643.71M.
- 2026-03-31: Common Stock, Value, IssuedUSD $47.00K; Additional Paid in Capital, Common StockUSD $877.88M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-1.01M; Retained Earnings (Accumulated Deficit)USD $-594.77M.
- 2025-12-31: Common Stock, Value, IssuedUSD $47.00K; Additional Paid in Capital, Common StockUSD $873.64M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-723.00K; Retained Earnings (Accumulated Deficit)USD $-577.23M.
- 2025-09-30: Common Stock, Value, IssuedUSD $47.00K; Additional Paid in Capital, Common StockUSD $869.42M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-818.00K; Retained Earnings (Accumulated Deficit)USD $-554.12M.
Quanterix Corporation Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $47.00K | $882.04M | $-1.17M | $-643.71M | $237.21M | 3 month · $4.21M | (m) | (m) |
| 2026-03-31 | $47.00K | $877.88M | $-1.01M | $-594.77M | $282.14M | 3 month · $4.53M | (m) | (m) |
| 2025-12-31 | $47.00K | $873.64M | $-723.00K | $-577.23M | $295.73M | 12 month · $20.72M | (m) | (m) |
| 2025-09-30 | $47.00K | $869.42M | $-818.00K | $-554.12M | $314.53M | 3 month · $5.47M | (m) | (m) |
| 2025-06-30 | $39.00K | $813.95M | $-928.00K | $-520.60M | $292.46M | 3 month · $5.37M | (m) | (m) |
| 2025-03-31 | $39.00K | $808.76M | $-1.82M | $-490.58M | $316.39M | 3 month · $5.46M | (m) | (m) |
| 2024-12-31 | $39.00K | $803.16M | $-3.08M | $-470.08M | $330.04M | 12 month · $19.99M | (m) | (m) |
| 2024-09-30 | $39.00K | $798.71M | $-1.41M | $-458.45M | $338.88M | 3 month · $4.66M | (m) | (m) |
| 2024-06-30 | $38.00K | $793.91M | $-3.07M | $-450.10M | $340.78M | 3 month · $5.23M 6 month · $10.49M | (m) | (m) |
| 2024-03-31 | $38.00K | $789.01M | $-2.95M | $-442.71M | $343.38M | 3 month · $5.26M | (m) | (m) |
| 2023-12-31 | $38.00K | $783.14M | $-1.67M | $-431.55M | $349.96M | 12 month · $16.82M | (m) | (m) |
| 2023-09-30 | $38.00K | $778.62M | $-3.13M | $-422.74M | $352.79M | 3 month · $4.34M 9 month · $12.50M | (m) | (m) |
| 2023-06-30 | $37.00K | $772.47M | $-2.74M | $-416.02M | $353.75M | 3 month · $4.21M 6 month · $8.15M | (m) | (m) |
| 2023-03-31 | $37.00K | $768.12M | $-2.50M | $-410.47M | $355.19M | 3 month · $3.94M | (m) | (m) |
| 2022-12-31 | $37.00K | $763.63M | $-2.54M | $-403.20M | $357.93M | 12 month · $15.38M | (m) | (m) |
| 2022-09-30 | $37.00K | $759.25M | $-3.00M | $-385.00M | $371.29M | 3 month · $2.76M 9 month · $11.72M | (m) | (m) |
| 2022-06-30 | $37.00K | $756.09M | $-2.20M | $-348.45M | $405.47M | 3 month · $5.16M 6 month · $8.96M | (m) | (m) |
| 2022-03-31 | $37.00K | $750.72M | $-756.00K | $-321.54M | $428.46M | 3 month · $3.80M | (m) | (m) |
| 2021-12-31 | $37.00K | $745.94M | $441.00K | $-305.46M | $442.79M | 12 month · $15.97M | (m) | (m) |
| 2021-09-30 | $37.00K | $739.86M | $1.05M | $-285.44M | $455.51M | 3 month · $4.01M 9 month · $11.04M | (m) | (m) |
| 2021-06-30 | $37.00K | $734.17M | $1.58M | $-269.77M | $466.01M | 3 month · $3.65M 6 month · $7.04M | (m) | (m) |
| 2021-03-31 | $36.00K | $728.13M | $1.18M | $-257.88M | $471.47M | 3 month · $3.39M | (m) | (m) |
| 2020-12-31 | $32.00K | $451.43M | $2.43M | $-247.77M | $205.82M | 12 month · $10.10M | (m) | (m) |
| 2020-09-30 | $32.00K | $446.23M | $734.00K | $-237.95M | $209.04M | 3 month · $2.36M 9 month · $6.97M | (m) | (m) |
| 2020-06-30 | $28.00K | $351.19M | $-26.00K | $-240.16M | $111.03M | 3 month · $2.50M 6 month · $4.61M | (m) | (m) |
| 2020-03-31 | $28.00K | $348.07M | $-1.20M | $-227.85M | $119.05M | 3 month · $2.11M | (m) | (m) |
| 2019-12-31 | $28.00K | $345.03M | $-153.00K | $-216.24M | $128.66M | 12 month · $6.39M | (m) | (m) |
| 2019-09-30 | $28.00K | $342.63M | $-1.14M | $-205.29M | $136.24M | 3 month · $1.83M 9 month · $4.71M | (m) | (m) |
| 2019-06-30 | $25.00K | $270.14M | (m) | $-195.42M | $74.75M | 3 month · $1.60M 6 month · $2.88M | (m) | (m) |
| 2019-03-31 | $23.00K | $219.04M | (m) | $-184.85M | $34.22M | 3 month · $1.28M | (m) | (m) |
| 2019-01-01 | (m) | (m) | (m) | $-175.45M | (m) | (m) | (m) | (m) |
| 2018-12-31 | $22.00K | $216.93M | (m) | $-175.89M | $41.06M | 12 month · $4.88M | $41.06M | 12 month · $20.00K |
| 2018-09-30 | $22.00K | $214.22M | (m) | $-166.55M | $47.69M | 3 month · $1.87M 9 month · $3.39M | (m) | 9 month · $53.00K |
| 2018-06-30 | $22.00K | $212.05M | (m) | $-158.90M | $53.17M | 3 month · $890.00K 6 month · $1.53M | (m) | 6 month · $53.00K |
| 2018-03-31 | $22.00K | $210.86M | (m) | $-151.55M | $59.33M | 3 month · $636.00K | (m) | 3 month · $53.00K |
| 2017-12-31 | $22.00K | $210.20M | (m) | $-144.35M | $65.87M | 12 month · $2.17M | $65.87M | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | $-115.11M | 12 month · $928.00K | $-115.11M | (m) |
| 2015-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-88.64M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |